|
News releases may contain forward-looking statements, subject to risks and uncertainties beyond Nuvo's control. All news releases were accurate when issued. Actual results could differ materially from those expressed and Nuvo undertakes no obligation to revise the information in light of future events.
Year: 2008 : 2007 : 2006 : 2005 : 2004
| December 29th, 2006 |
Nuvo Receives Approvable Letter from U.S. FDA for Pennsaid |
| December 22nd, 2006 |
Nuvo Licenses Canadian Pennsaid Plus Rights to Subsidiary of Paladin |
| November 20th, 2006 |
Nuvo Announces Warrant Incentive Program |
| November 9th, 2006 |
Nuvo Announces Third Quarter Financial Results |
| August 14th, 2006 |
Nuvo Announces Second Quarter Financial Results |
| July 13th, 2006 |
Nuvo's Pennsaid NDA Resubmission Accepted for Review by U.S. FDA |
| June 20th, 2006 |
Nuvo Research Completes Bought Deal Financing for Gross Proceeds of $15 Million |
| May 31st, 2006 |
Nuvo Enters Into a Bought Deal Agreement for Gross Proceeds of $15 Million |
| May 6th, 2006 |
Nuvo Announces First Quarter Financial Results |
| Apr 26th, 2006 |
Nuvo Completes Analysis of Long-Term Safety Data for Pennsaid® |
| Apr 26th, 2006 |
Nuvo Research Announces Details of 2006 Annual General Meeting |
| Mar 6th, 2006 |
Nuvo Announces Year-End Financial Results |
| Mar 2nd, 2006 |
Nuvo Announces Pennsaid® Data Published in The Journal of Rheumatology |
| Mar 1st, 2006 |
Nuvo Provides Update on Long-Term Safety Trial for Pennsaid® |
| Jan 17th, 2006 |
Nuvo Sells Pennsaid Rights to Paladin Subsidiary |
| Jan 16th, 2006 |
Nuvo Detailed Phase III Trial Results |
| Jan 12th, 2006 |
Nuvo Sells Markham Head Office |
All news releases are in PDF format. To view the news releases you will need Adobe Acrobat Reader installed on your computer.
|
